You are here

CCCS invites feedback over merger concerns on PAH deals

Response will help watchdog assess if planned consolidation of two clinical laboratories will reduce competition


THE Competition and Consumer Commission of Singapore (CCCS) is inviting public feedback on the two-year commitments proposed by Pathology Asia Holdings (PAH) to address competition concerns in its planned merger of two private clinical laboratories.

PAH, a unit of private...

Market voices on: